Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 37

1.

The application of W-plasty combined Botox-A injection in treating sunk scar on the face.

Chen H, Pan W, Zhang J, Cheng H, Tan Q.

Medicine (Baltimore). 2018 Jul;97(30):e11427. doi: 10.1097/MD.0000000000011427.

2.

Botulinum toxins for the prevention of migraine in adults.

Herd CP, Tomlinson CL, Rick C, Scotton WJ, Edwards J, Ives N, Clarke CE, Sinclair A.

Cochrane Database Syst Rev. 2018 Jun 25;6:CD011616. doi: 10.1002/14651858.CD011616.pub2. Review.

PMID:
29939406
3.

Duration of effectiveness of Botulinum toxin type A in excessive gingival display: a systematic review and meta-analysis.

Chagas TF, Almeida NV, Lisboa CO, Ferreira DMTP, Mattos CT, Mucha JN.

Braz Oral Res. 2018;32:e30. doi: 10.1590/1807-3107bor-2018.vol32.0030. Epub 2018 May 7. Review.

4.

Effect of therapeutic exercise on knee osteoarthritis after intra-articular injection of botulinum toxin type A, hyaluronate or saline: A randomized controlled trial.

Bao X, Tan JW, Flyzik M, Ma XC, Liu H, Liu HY.

J Rehabil Med. 2018 Jun 15;50(6):534-541. doi: 10.2340/16501977-2340.

5.

Topical Botulinum Toxin Type A Liposomal Cream for Primary Axillary Hyperhidrosis: A Double-Blind, Randomized, Split-Site, Vehicle-Controlled Study.

Lueangarun S, Sermsilp C, Tempark T.

Dermatol Surg. 2018 Aug;44(8):1094-1101. doi: 10.1097/DSS.0000000000001532.

PMID:
29659406
6.

Modern management of esophageal achalasia: From pathophysiology to treatment.

Schlottmann F, Herbella F, Allaix ME, Patti MG.

Curr Probl Surg. 2018 Jan;55(1):10-37. doi: 10.1067/j.cpsurg.2018.01.001. Epub 2018 Jan 31. Review. No abstract available.

PMID:
29548347
7.

Attention to Infection Prevention in Medical Aesthetic Clinics.

Hotta TA.

Plast Surg Nurs. 2018 Jan/Mar;38(1):17-24. doi: 10.1097/PSN.0000000000000215.

PMID:
29494408
8.

Effects of Botulinum Toxin on Improving Facial Surgical Scars: A Prospective, Split-Scar, Double-Blind, Randomized Controlled Trial.

Hu L, Zou Y, Chang SJ, Qiu Y, Chen H, Gang M, Jin Y, Lin X.

Plast Reconstr Surg. 2018 Mar;141(3):646-650. doi: 10.1097/PRS.0000000000004110.

PMID:
29481395
9.

Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study.

Blumenfeld AM, Stark RJ, Freeman MC, Orejudos A, Manack Adams A.

J Headache Pain. 2018 Feb 5;19(1):13. doi: 10.1186/s10194-018-0840-8.

10.

The Cellular Response of Keloids and Hypertrophic Scars to Botulinum Toxin A: A Comprehensive Literature Review.

Austin E, Koo E, Jagdeo J.

Dermatol Surg. 2018 Feb;44(2):149-157. doi: 10.1097/DSS.0000000000001360. Review.

PMID:
29401161
11.

Paradoxical Frontalis Activation: An Underrecognized Consequence of Facial Palsy.

Cooper L, Izard C, Harries V, Neville C, Venables V, Malhotra R, Nduka C.

Plast Reconstr Surg. 2018 Feb;141(2):263e-270e. doi: 10.1097/PRS.0000000000004057.

PMID:
29369999
12.

A Randomized Study to Assess the Efficacy of Skin Rejuvenation Therapy in Combination With Neurotoxin and Full Facial Filler Treatments.

Dayan SH, Ho TT, Bacos JT, Gandhi ND, Kalbag A, Gutierrez-Borst S.

J Drugs Dermatol. 2018 Jan 1;17(1):48-54.

PMID:
29320587
13.

Botulinum toxin for motor and phonic tics in Tourette's syndrome.

Pandey S, Srivanitchapoom P, Kirubakaran R, Berman BD.

Cochrane Database Syst Rev. 2018 Jan 5;1:CD012285. doi: 10.1002/14651858.CD012285.pub2. Review.

PMID:
29304272
14.

The Impact of Botulinum Toxin on Brow Height and Morphology: A Randomized Controlled Trial.

El-Khoury JS, Jabbour SF, Awaida CJ, Rayess YA, Kechichian EG, Nasr MW.

Plast Reconstr Surg. 2018 Jan;141(1):75-78. doi: 10.1097/PRS.0000000000003919.

PMID:
29280866
15.

Botulinum toxin type A therapy for cervical dystonia.

Castelão M, Marques RE, Duarte GS, Rodrigues FB, Ferreira J, Sampaio C, Moore AP, Costa J.

Cochrane Database Syst Rev. 2017 Dec 12;12:CD003633. doi: 10.1002/14651858.CD003633.pub3. Review.

PMID:
29230798
16.

Interventions for managing skeletal muscle spasticity following traumatic brain injury.

Synnot A, Chau M, Pitt V, O'Connor D, Gruen RL, Wasiak J, Clavisi O, Pattuwage L, Phillips K.

Cochrane Database Syst Rev. 2017 Nov 22;11:CD008929. doi: 10.1002/14651858.CD008929.pub2. Review.

PMID:
29165784
17.

Are paraspinous intramuscular injections of botulinum toxin a (BoNT-A) efficient in the treatment of chronic low-back pain? A randomised, double-blinded crossover trial.

Cogné M, Petit H, Creuzé A, Liguoro D, de Seze M.

BMC Musculoskelet Disord. 2017 Nov 15;18(1):454. doi: 10.1186/s12891-017-1816-6.

18.

Combination Therapy for Male Cosmetic Patients.

Gold MH.

Dermatol Clin. 2018 Jan;36(1):69-73. doi: 10.1016/j.det.2017.09.009. Review.

PMID:
29108549
19.

Efficacy and safety of abobotulinumtoxinA in spastic lower limb: Randomized trial and extension.

Gracies JM, Esquenazi A, Brashear A, Banach M, Kocer S, Jech R, Khatkova S, Benetin J, Vecchio M, McAllister P, Ilkowski J, Ochudlo S, Catus F, Grandoulier AS, Vilain C, Picaut P; International AbobotulinumtoxinA Adult Lower Limb Spasticity Study Group.

Neurology. 2017 Nov 28;89(22):2245-2253. doi: 10.1212/WNL.0000000000004687. Epub 2017 Nov 1.

20.

Effectiveness, Safety, and Predictors of Response to Botulinum Toxin Type A in Refractory Masticatory Myalgia: A Retrospective Study.

Khawaja SN, Scrivani SJ, Holland N, Keith DA.

J Oral Maxillofac Surg. 2017 Nov;75(11):2307-2315. doi: 10.1016/j.joms.2017.01.031.

PMID:
29078865

Supplemental Content

Loading ...
Support Center